The next hype narrative after crypto has its bull run and seems “tapped out” will be psychedelics having a clinical use case and the runway for approval lines up perfectly. Compass has established itself as the best positioned player in the game and the shares have never been more reasonable. I am a continued buyer on anything 6 or below just because this is a...
Long term buys from here down to a possible gap fill (low 30's from 2019-2020 pre pump to 300s) have a great R:R if you have a long enough time horizon. Company is putting in the money now to have effortless positive earnings/share in the future. Hard to ignore at these levels with the CEO still so heavily invested and holding strong. Long term price target > $100...
Long term buys from here down to a possible gap fill (low 30’s from 2019-2020 pre pump to 300s) have a great R:R if you have a long enough time horizon. Company is putting in the money now to have effortless positive earnings/share in the future. Hard to ignore at these levels with the CEO still so heavily invested and holding strong. Long term price target >$100...